EQS Group AG
DGAP-DD: PNE WIND AG english
Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG
Directors' Dealings notification transmitted by DGAP â a service of EQS Group
The person with duty of notification is solely responsible for the content
of this announcement.
Details of the person subject to the disclosure requirement
Company: VF VermÃ¶gensverwaltung GmbH
Enterprise Financial Reports Third Quarter 2014 Results
ST. LOUIS, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Enterprise Financial Services Corp (Nasdaq:EFSC) (the "Company") reported net income of $8.2 million for the quarter ended September 30, 2014, an increase of $1.0 million, or 14%, as compared to the linked second quarter. Net income per diluted share also increased 14% to $0.41 for the quarter ended September 30, 2014, compared to $0.36 per diluted share for the linked second quarter. The linked quarter increase in net income was due to robust portfolio loan growth driving an 6% annualized increase in core net interest income, as well as reduced provision from loan losses from continued strong credit quality and increased fee income from a $0.9 million closing fee recorded in the quarter. Third quarter 2014 net income was 3% lower than the $8.4 million reported in the prior year period and diluted earnings per share were 7% lower than the $0.44 reported a year ago. The year over year decrease in net income and diluted earnings per share was primarily due to a $2.5 million reduction in net revenue from purchase credit impaired ("PCI") loans due to declining balances and lower accelerated cash flows from these loans. Excluding the impact of PCI loans, core pretax income increased 5% in the third quarter of 2014 compared to the prior year period.
Superior Uniform Group, Inc.
Superior Uniform Group Announces Fiscal 2014 Third Quarter Operating Results
SEMINOLE, Fla., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Superior Uniform Group, Inc. (Nasdaq:SGC), manufacturer of uniforms, career apparel and accessories, today announced that for the third quarter ended September 30, 2014, net sales were $52.3 million compared with 2013 third quarter net sales of $44.2 million. Net income was $3.4 million, or $0.48 per diluted share, compared with net income of $1.5 million, or $0.24 per diluted share, in the 2013 third quarter.
Rich Pharmaceuticals, Inc.
Rich Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application to FDA for the Treatment of Acute Myelocytic Leukemia and Myelodysplastic Syndrome
BEVERLY HILLS, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company"), a clinical-stage biotechnology company focused on developing innovative therapies in oncology, announced today that it has submitted an investigational new drug (IND) application to conduct a Phase 2 clinical trial for its lead compound RP-323 in Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) with the U.S. Food and Drug Administration (FDA). Rich plans to initiate a multicenter, Phase 2 clinical study using RP-323 to treat AML and MDS patients. According to the American Cancer Society surveillance research group in 2014, it is estimated there will be 18,860 new cases of AML and 10,460 deaths from acute myeloid leukemia (AML) in the United States. Myelodysplastic syndrome is a type of cancer in which the bone marrow does not make enough healthy blood cells and there are abnormal (blast) cells in the blood and/or bone marrow.
Diet Doc Weight Loss
Diet Doc Announces New, Exclusive Diet Plans and Prescription Diet Pills for Safe and Fast Fat Loss
NEW YORK, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Although dieters have many options when searching for the best diet pills and weight loss programs, care must be taken when choosing a program that is right for them. Very often, diet plans will offer quick fat loss results that serve general dieting needs but do not address the patient's personal and unique causes of weight gain. Because of this, dieters often see a return of the weight. Diet Doc developed their weight loss programs and exclusive diet pills with this principle in mind and have been successful in helping people throughout the country improve their health through safe and fast weight loss.
SoldierSocks and Airpower Foundation Donate Robotic Exoskeleton to VA North Texas Health Care System
STAMFORD, Conn., Oct. 23, 2014 (GLOBE NEWSWIRE) -- SoldierSocks, a non-profit foundation focused on helping veterans, announced today that the VA North Texas Health Care System is the next recipient of an Ekso Bionics™ suit (OTCQB:EKSO). The Ekso GT™ will help injured veterans walk again at the Dallas VA Medical Center, Spinal Cord Injury Center (SCI), which serves over 900 Veterans with spinal cord injury/disorder including 200 patients with multiple sclerosis in the southwest region. They will accept the suit in a donation ceremony in a prelude to Sky Ball festivities, on October 24, 2014 at 11:30 am in the Gallery room at the Westin Dallas Fort Worth Airport, 4545 W. John Carpenter Freeway, Irving TX 75063. A special appearance will be made from SoldierSocks' first Ekso recipient, veteran Dan Rose, who will walk in an Ekso device with veteran Gary Linfoot, who also received an Ekso suit in part from Airpower last year. Additional attendees of note include Jim Palmersheim of American Airlines, Roman Palomares of Airpower Foundation and on hand to accept the donation will be Mr. Jeff Milligan, Director, VA North Texas Health Care System.